{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:42:39Z","timestamp":1788306159603,"version":"build-2803163510"},"reference-count":37,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpem-2019-0403_s_999_w2aab3b7c16b1b6b1aab1c18b1Aa\">\n                  <jats:title id=\"d679415e59872_w2aab3b7c16b1b6b1aab1c18b1aAa\">Background<\/jats:title>\n                  <jats:p>The prevalence of childhood obesity and its related comorbidities in Malaysia are alarming. Malaysia ranked second in childhood obesity among South-east Asian countries with a prevalence of 12.7%. This study was conducted to investigate the prevalence of non-alcoholic fatty liver disease (NAFLD) among obese children and to ascertain the predictors associated with NAFLD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2019-0403_s_998_w2aab3b7c16b1b6b1aab1c18b2Aa\">\n                  <jats:title id=\"d679415e59880_w2aab3b7c16b1b6b1aab1c18b2aAa\">Methods<\/jats:title>\n                  <jats:p>NAFLD was diagnosed via ultrasonographic evidence of fatty liver in obese and overweight children who presented to the Paediatric Obesity Clinic of University Malaya Medical Centre (UMMC), Malaysia. Demographic, anthropometric, clinical and biochemical parameters were analysed and compared between the NAFLD and non-NAFLD groups. Statistical analyses were carried out.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2019-0403_s_997_w2aab3b7c16b1b6b1aab1c18b3Aa\">\n                  <jats:title id=\"d679415e59888_w2aab3b7c16b1b6b1aab1c18b3aAa\">Results<\/jats:title>\n                  <jats:p>Twenty-one out of 33 obese and overweight children (63.6%) were found to have NAFLD. We found that 62% of our study population in the NAFLD group had metabolic syndrome based on the definition by the International Diabetes Federation (IDF). Mean body mass index (BMI), waist circumference (WC), triglyceride (TG) and alanine aminotransferase (ALT) were found to be significantly greater in the NAFLD group compared to the non-NAFLD group (35.2 [6.1] vs. 29.3 [4.7] kg\/m<jats:sup>2<\/jats:sup> [p-value 0.007]; 104.1 [11.4] vs. 94.1 [12] cm [p-value 0.034]; 1.5 [0.9] vs. 0.9 [0.3] mmol\/L [p-value 0.002]; 60.7 [53.8] vs. 27.3 [13] U\/L [p-value 0.007]). Multivariate regression analysis revealed TG as the independent predictor for NAFLD, with an odds ratio of 41.7 (95% confidence interval [CI] 0.001, 0.819) (p-value 0.04).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpem-2019-0403_s_996_w2aab3b7c16b1b6b1aab1c18b4Aa\">\n                  <jats:title id=\"d679415e59899_w2aab3b7c16b1b6b1aab1c18b4aAa\">Conclusions<\/jats:title>\n                  <jats:p>Prevalence of NAFLD among children who are obese and overweight is alarming with 62% having metabolic syndrome. TG was found to be a strong predictor for NAFLD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpem-2019-0403","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T09:02:00Z","timestamp":1578733320000},"page":"247-253","source":"Crossref","is-referenced-by-count":24,"title":["Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity"],"prefix":"10.1515","volume":"33","author":[{"given":"Rashdan Zaki","family":"Mohamed","sequence":"first","affiliation":[{"name":"Department of Paediatrics , Hospital Putrajaya , Putrajaya , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Yazid","family":"Jalaludin","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Faculty of Medicine , Universiti Malaya , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azriyanti","family":"Anuar Zaini","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Faculty of Medicine , Universiti Malaya , Kuala Lumpur , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,1,11]]},"reference":[{"key":"2023040101034632850_j_jpem-2019-0403_ref_001_w2aab3b7c16b1b6b1ab1b7b1Aa","doi-asserted-by":"crossref","unstructured":"Petta S, Gastaldelli A, Rebelos E, Bugianesi E, Messa P, et al. Pathophysiology of non alcoholic fatty liver disease. Int J Mol Sci 2016;17:2082.","DOI":"10.3390\/ijms17122082"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_002_w2aab3b7c16b1b6b1ab1b7b2Aa","doi-asserted-by":"crossref","unstructured":"Chan DF, Li AM, Chu WC, Chan MH, Wong EM, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord 2004;28:1257\u201363.","DOI":"10.1038\/sj.ijo.0802734"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_003_w2aab3b7c16b1b6b1ab1b7b3Aa","doi-asserted-by":"crossref","unstructured":"Lavine JE, Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis 2004;8:549\u201358.","DOI":"10.1016\/j.cld.2004.04.010"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_004_w2aab3b7c16b1b6b1ab1b7b4Aa","doi-asserted-by":"crossref","unstructured":"Malespin M, Sleesman B, Lau A, Wong SS, Cotler SJ. Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children. J Clin Gastroenterol 2015;49:345\u20139.","DOI":"10.1097\/MCG.0000000000000121"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_005_w2aab3b7c16b1b6b1ab1b7b5Aa","doi-asserted-by":"crossref","unstructured":"Grandison GA, Angulo P. Can NASH be diagnosed, graded, and staged noninvasively? Clin Liver Dis 2012;16:567\u201385.","DOI":"10.1016\/j.cld.2012.05.001"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_006_w2aab3b7c16b1b6b1ab1b7b6Aa","doi-asserted-by":"crossref","unstructured":"Vos MB, Abrams SH, Barlow SE, Caprio S, Daniels SR, et al. NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). J Pediatr Gastroenterol Nutr 2017;64:319\u201334.","DOI":"10.1097\/MPG.0000000000001482"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_007_w2aab3b7c16b1b6b1ab1b7b7Aa","doi-asserted-by":"crossref","unstructured":"Kim CH, Younossi ZM. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. Cleve Clin J Med 2008;75:721\u20138.","DOI":"10.3949\/ccjm.75.10.721"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_008_w2aab3b7c16b1b6b1ab1b7b8Aa","doi-asserted-by":"crossref","unstructured":"Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917\u201323.","DOI":"10.1053\/jhep.2003.50161"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_009_w2aab3b7c16b1b6b1ab1b7b9Aa","doi-asserted-by":"crossref","unstructured":"Goyal NP, Schwimmer JB. The progression and natural history of pediatric nonalcoholic fatty liver disease. Clin Liver Dis 2016;20:325\u201338.","DOI":"10.1016\/j.cld.2015.10.003"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_010_w2aab3b7c16b1b6b1ab1b7c10Aa","doi-asserted-by":"crossref","unstructured":"Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr 2007;61:877\u201383.","DOI":"10.1038\/sj.ejcn.1602588"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_011_w2aab3b7c16b1b6b1ab1b7c11Aa","unstructured":"Wan YP, Xu RY, Fang H, Lu LP, Zhang XM, et al. The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai. Zhonghua Gan Zang Bing Za Zhi 2007;15:644\u20138."},{"key":"2023040101034632850_j_jpem-2019-0403_ref_012_w2aab3b7c16b1b6b1ab1b7c12Aa","doi-asserted-by":"crossref","unstructured":"Kim JY, Cho J, Yang HR. Biochemical predictors of early onset non-alcoholic fatty liver disease in young children with obesity. J Korean Med Sci 2018;33:e122.","DOI":"10.3346\/jkms.2018.33.e122"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_013_w2aab3b7c16b1b6b1ab1b7c13Aa","unstructured":"Flegal KM, Cole TJ. Construction of LMS parameters for the Centers for Disease Control and Prevention 2000 growth charts. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2013 Feb 11."},{"key":"2023040101034632850_j_jpem-2019-0403_ref_014_w2aab3b7c16b1b6b1ab1b7c14Aa","doi-asserted-by":"crossref","unstructured":"Poh BK, Jannah AN, Chong LK, Ruzita AT, Ismail MN, et al. Waist circumference percentile curves for Malaysian children and adolescents aged 6.0\u201316.9 years. Int J Pediatr Obes 2011;6:229\u201335.","DOI":"10.3109\/17477166.2011.583658"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_015_w2aab3b7c16b1b6b1ab1b7c15Aa","doi-asserted-by":"crossref","unstructured":"Zimmet AP. Metabolic syndrome-a new world-wide definition. A consensus statement from the International Diabetes Federation. Diabet Med 2006;23:469\u201380.","DOI":"10.1111\/j.1464-5491.2006.01858.x"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_016_w2aab3b7c16b1b6b1ab1b7c16Aa","doi-asserted-by":"crossref","unstructured":"Gupta R, Bhangoo A, Matthews NA, Anhalt H, Matta Y, et al. The prevalence of non-alcoholic fatty liver disease and metabolic syndrome in obese children. J Pediatr Endocrinol Metab 2011;24:907\u201311.","DOI":"10.1515\/JPEM.2011.282"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_017_w2aab3b7c16b1b6b1ab1b7c17Aa","doi-asserted-by":"crossref","unstructured":"Anderson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, et al. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and meta-analysis. PLoS One 2015;10:e0140908.","DOI":"10.1371\/journal.pone.0140908"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_018_w2aab3b7c16b1b6b1ab1b7c18Aa","doi-asserted-by":"crossref","unstructured":"Namakin K, Hosseini M, Zardast M, Mohammadifard M. Prevalence of non-alcoholic fatty liver disease (NAFLD) and its clinical characteristics in overweight and obese children in the south east of Iran, 2017. Hepat Mon 2018;18:e83525.","DOI":"10.5812\/hepatmon.83525"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_019_w2aab3b7c16b1b6b1ab1b7c19Aa","doi-asserted-by":"crossref","unstructured":"Suzuki A, Abdelmalek MF, Schwimmer JB, Lavine JE, Scheimann AO, et al. Nonalcoholic Steatohepatitis Clinical Research Network. Association between puberty and features of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2012;10:786\u201394.","DOI":"10.1016\/j.cgh.2012.01.020"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_020_w2aab3b7c16b1b6b1ab1b7c20Aa","doi-asserted-by":"crossref","unstructured":"Temple J, Cordero P, Li J, Nguyen V, Oben J. A guide to non-alcoholic fatty liver disease in childhood and adolescence. Int J Mol Sci 2016;17:947.","DOI":"10.3390\/ijms17060947"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_021_w2aab3b7c16b1b6b1ab1b7c21Aa","doi-asserted-by":"crossref","unstructured":"Fan R, Wang J, Du J. Association between body mass index and fatty liver risk: a dose-response analysis. Sci Rep 2018;8:15273.","DOI":"10.1038\/s41598-018-33419-6"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_022_w2aab3b7c16b1b6b1ab1b7c22Aa","doi-asserted-by":"crossref","unstructured":"Saida T, Fukushima W, Ohfuji S, Kondo K, Matsunaga I, et al. Effect modification of body mass index and body fat percentage on fatty liver disease in a Japanese population. J Gastroenterol Hepatol 2014;29:128\u201336.","DOI":"10.1111\/jgh.12377"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_023_w2aab3b7c16b1b6b1ab1b7c23Aa","doi-asserted-by":"crossref","unstructured":"Loomis AK, Kabadi S, Preiss D, Hyde C, Bonato V, et al. Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies. J Clin Endocrinol Metab 2016;101:945\u201352.","DOI":"10.1210\/jc.2015-3444"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_024_w2aab3b7c16b1b6b1ab1b7c24Aa","doi-asserted-by":"crossref","unstructured":"Miyake T, Kumagi T, Hirooka M, Furukawa S, Koizumi M, et al. Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort study. J Gastroenterol 2013;48:413\u201322.","DOI":"10.1007\/s00535-012-0650-8"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_025_w2aab3b7c16b1b6b1ab1b7c25Aa","doi-asserted-by":"crossref","unstructured":"Wang L, Guo J, Lu J. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females. Oncotarget 2016;7:35632\u201342.","DOI":"10.18632\/oncotarget.9691"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_026_w2aab3b7c16b1b6b1ab1b7c26Aa","doi-asserted-by":"crossref","unstructured":"Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res 2009;48:1\u201326.","DOI":"10.1016\/j.plipres.2008.08.001"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_027_w2aab3b7c16b1b6b1ab1b7c27Aa","doi-asserted-by":"crossref","unstructured":"Tomizawa M, Kawanabe Y, Shinozaki F, Sato S, Motoyoshi Y, et al. Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes. Biomed Rep 2014;2:633\u20136.","DOI":"10.3892\/br.2014.309"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_028_w2aab3b7c16b1b6b1ab1b7c28Aa","doi-asserted-by":"crossref","unstructured":"Tominaga K, Fujimoto E, Suzuki K, Hayashi M, Ichikawa M, et al. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Environ Health Prev Med 2009;14:142\u20139.","DOI":"10.1007\/s12199-008-0074-5"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_029_w2aab3b7c16b1b6b1ab1b7c29Aa","doi-asserted-by":"crossref","unstructured":"Morimoto A, Nishimura R, Kanda A, Sano H, Matsudaira T, et al. Waist circumference estimation from BMI in Japanese children. Diabetes Res Clin Pract 2007;75:96\u20138.","DOI":"10.1016\/j.diabres.2006.05.022"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_030_w2aab3b7c16b1b6b1ab1b7c30Aa","doi-asserted-by":"crossref","unstructured":"Fadzlina AA, Harun F, Haniza MN, Al Sadat N, Murray L, et al. Metabolic syndrome among 13 year old adolescents: prevalence and risk factors. BMC Public Health 2014;14:S7.","DOI":"10.1186\/1471-2458-14-S3-S7"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_031_w2aab3b7c16b1b6b1ab1b7c31Aa","doi-asserted-by":"crossref","unstructured":"Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. Crit Rev Clin Lab Sci 1980;12:1\u201358.","DOI":"10.3109\/10408368009108725"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_032_w2aab3b7c16b1b6b1ab1b7c32Aa","doi-asserted-by":"crossref","unstructured":"Poynard T, Ratziu V, Naveau S, Thabut D, Charlotte F, et al. The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis. Comp Hepatol 2005;4:10.","DOI":"10.1186\/1476-5926-4-10"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_033_w2aab3b7c16b1b6b1ab1b7c33Aa","doi-asserted-by":"crossref","unstructured":"Papadia FS, Marinari GM, Camerini G, Murelli F, Carlini F, et al. Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. Obes Surg 2004;14:952\u20138.","DOI":"10.1381\/0960892041719644"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_034_w2aab3b7c16b1b6b1ab1b7c34Aa","doi-asserted-by":"crossref","unstructured":"Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745\u201350.","DOI":"10.1053\/gast.2002.35354"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_035_w2aab3b7c16b1b6b1ab1b7c35Aa","doi-asserted-by":"crossref","unstructured":"Tovo CV, Villela-Nogueira CA, Leite NC, Panke CL, Port GZ, et al. Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD). Ann Hepatol 2019;18:445\u20139.","DOI":"10.1016\/j.aohep.2018.09.003"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_036_w2aab3b7c16b1b6b1ab1b7c36Aa","doi-asserted-by":"crossref","unstructured":"Sasso M, Beaugrand M, De Ledinghen V, Douvin C, Marcellin P, et al. Controlled attenuation parameter (CAP): a novel VCTE\u2122 guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: preliminary study and validation in a cohort of patients with chronic liver disease from various causes. Ultrasound Med Biol 2010;36:1825\u201335.","DOI":"10.1016\/j.ultrasmedbio.2010.07.005"},{"key":"2023040101034632850_j_jpem-2019-0403_ref_037_w2aab3b7c16b1b6b1ab1b7c37Aa","doi-asserted-by":"crossref","unstructured":"Sigrist RM, Liau J, Kaffas AE, Chammas MC, Willmann JK. Ultrasound elastography: review of techniques and clinical applications. Theranostics 2017;7:1303\u201329.","DOI":"10.7150\/thno.18650"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/jpem\/33\/2\/article-p247.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0403\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0403\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T17:51:44Z","timestamp":1680371504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2019-0403\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,11]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2,5]]},"published-print":{"date-parts":[[2020,2,25]]}},"alternative-id":["10.1515\/jpem-2019-0403"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2019-0403","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,11]]}}}